Clinical Trial

AFS Compared to AHC in Treatment of Necrotizing Fasciitis NF

Study acronym: NF
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated December 30, 2024 (before its estimated August 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Necrotizing Fasciitis (NF) is a potentially life-threatening soft tissue infection. This study is comparing acellular fish skin graft (AFS) to standard of care allograft (AHC) in the treatment of NF. The purpose of this study is to compare clinical outcomes and time until autograft take in patients that were treated with AHC or AFS prior to permanent autografting to treat NF.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-10-02; most recent amendment 2024-12-27.
Status change: Recruiting → Active, Not Recruiting 2024-12-27
Trial Details
NCT Number NCT06073301
Lead Sponsor Kerecis Ltd.
Collaborators: Joseph M. Still Research Foundation, Inc.
Conditions Necrotizing Fasciitis
Enrollment 30 participants
Start Date 2023-08-01
Primary Completion 2025-08-01 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2024-12-30